Every ashwagandha label mentions withanolides, usually as a percentage — 5%, 8%, 10%. But most people buying the supplement couldn’t say what a withanolide actually is, or why that number matters more than the word “ashwagandha” itself.
Withanolides are the reason ashwagandha extracts differ so much in potency, even when they come from the same plant. Understanding what they are — and what’s actually been proven about them in humans versus in a test tube — makes it much easier to evaluate a product label honestly.
What Is a Withanolide?
Withanolides are a class of naturally occurring steroidal lactones — organic compounds built on a 28-carbon (C28) steroid backbone known as an ergostane skeleton. Structurally, they resemble plant steroids more than they resemble hormones, though their name sometimes leads people to assume otherwise.
They were first isolated from ashwagandha (Withania somnifera) in the 1960s, which is where the compound class gets its name. Since then, researchers have identified hundreds of related withanolide compounds, both in ashwagandha and in other plants in the same botanical family (Withanolide structural overview).
Ashwagandha contains more than 40 identified withanolides and related glycowithanolides, but only a handful are considered pharmacologically significant in the compound’s traditional and modern uses.
The Main Withanolides in Ashwagandha
Withanolide A is one of the most studied compounds in root extracts and is associated in research with neuroprotective and cognitive effects, including influence on neurite outgrowth and memory-related pathways.
Withaferin A is the most extensively researched withanolide overall, with a large body of preclinical work on its anti-inflammatory activity. It appears to work partly by inhibiting NF-κB, a protein complex that drives inflammatory signaling inside cells (Withaferin A and NF-κB signaling — PMC). Withaferin A is also the withanolide most studied for anticancer activity in laboratory and animal models — this remains preclinical research, not an approved or proven human treatment.
Sitoindosides VII–X are glycowithanolides concentrated more in root extracts and have been associated in animal studies with anti-stress and adaptogenic effects.
Withanone and several related compounds are found in higher concentrations in the leaves rather than the root, which is part of why root-only and root-plus-leaf extracts behave differently in the body.
Root vs. Leaf: Why It Changes the Withanolide Profile
Ashwagandha’s withanolide content isn’t uniform across the plant. Root and leaf tissue contain different ratios of individual withanolides, which is the underlying reason branded extracts like KSM-66 (root-only) and Sensoril (root-and-leaf) are associated with somewhat different effects in research, despite coming from the same species.
This is also why a withanolide percentage alone doesn’t tell the full story. Two products standardized to “5% withanolides” can contain a different mix of individual compounds depending on which part of the plant — and which extraction method — was used.
Why Standardization and Bioavailability Matter
Not all withanolide content translates equally into what the body actually absorbs. A randomized crossover study comparing four commercial ashwagandha extracts with different withanolide standardizations found that the extract with the highest withanolide glycoside concentration had dramatically better oral bioavailability than lower-standardization extracts, even when doses were adjusted to deliver the same total withanolide amount (bioavailability comparison of ashwagandha extracts — PMC).
In practical terms, this means a higher withanolide percentage on a label isn’t just a marketing number — it can meaningfully affect how much of the active compound actually reaches the bloodstream, which is one reason patented, clinically studied extracts tend to outperform unstandardized generic ones in research.
What the Clinical Evidence Actually Supports
This is where it’s important to separate three different levels of evidence, since ashwagandha research spans all three:
Traditional use. Ashwagandha has centuries of use in Ayurvedic medicine as a general tonic for vitality, sleep, and stress resilience. This history doesn’t constitute clinical proof, but it’s part of why the plant was investigated scientifically in the first place.
Mechanistic and preclinical studies. Much of what’s known about individual withanolides — their effect on NF-κB, amyloid-beta aggregation, mitochondrial function, or cancer cell lines — comes from in vitro or animal research. This work explains how withanolides might work, but it doesn’t establish that a supplement will produce the same effect in a person.
Human randomized controlled trials (RCTs). This is the strongest tier of evidence, and it’s where most of the credible, product-relevant claims about ashwagandha extracts come from — primarily standardized studies on stress, cortisol, sleep, and certain hormone markers. For example, a 60-day RCT using a standardized 5%-withanolide root extract found a statistically significant reduction in serum cortisol compared to placebo in adults with chronic stress (Chandrasekhar et al., 2012 — PMC).
The gap between these tiers matters. Withaferin A’s anticancer and neuroprotective activity, for instance, is well documented in cell and animal studies, but it has not been established as a treatment for cancer or Alzheimer’s disease in humans, and no legitimate ashwagandha supplement should be marketed that way.
Does a Higher Withanolide Percentage Always Mean a Better Product?
Not automatically. Withanolide percentage is one meaningful quality marker, but it isn’t the only one. Extraction method, root-to-leaf ratio, and — critically — whether the specific extract has been tested in human clinical trials all affect real-world results. A generic extract listing a high withanolide percentage without third-party verification or supporting human research carries more uncertainty than a lower-percentage extract with a validated clinical track record.
Are Withanolides Safe?
Withanolides, particularly from root-based extracts, are generally well tolerated in the doses used in clinical research. Because leaf tissue tends to carry a different and sometimes more concentrated withanolide and alkaloid profile, root-and-leaf extracts may be more likely to cause drowsiness in sensitive individuals.
Ashwagandha extracts are not recommended for people with thyroid or autoimmune conditions, and may interact with thyroid medication, sedatives, or drugs for diabetes and blood pressure, regardless of the specific withanolide profile involved. Anyone in these categories, or who is pregnant or breastfeeding, should speak with a healthcare provider before use.
Frequently Asked Questions
No. Withanolides share a steroid-like chemical backbone, but they are plant compounds (phytosterols), not pharmaceutical steroids or hormones, and they don’t function the same way in the body.
Because extraction method, plant part used (root vs. leaf), and standardization process all affect how concentrated the final withanolide content is — there’s no single universal standard across the industry.
Not necessarily. Bioavailability, the specific mix of individual withanolides, and clinical validation for that exact extract all affect real-world potency, not percentage alone.
No. While individual withanolides like withaferin A show promising activity in laboratory and animal studies for these conditions, none of this has been established as a treatment in humans, and ashwagandha supplements should not be used as a substitute for medical care.
No. Root-only extracts and root-and-leaf extracts differ in which specific withanolides dominate, which is part of why they’re associated with somewhat different effects in research.
Long-term safety data beyond several months is limited for most standardized extracts. Periodic breaks and check-ins with a healthcare provider are a reasonable approach for extended use.
Final Thoughts
Withanolides are the compound class responsible for most of ashwagandha’s studied effects, but not all withanolides — or all extracts — are equivalent. The strongest evidence for real-world benefits comes from human clinical trials on specific, standardized extracts, not from the withanolide percentage on a label alone.
If you’re comparing specific products built around this compound class, see our full breakdown of the best KSM-66 ashwagandha supplements for options ranked by quality, dosage, and value.
